Janux Therapeutics, Inc. (JANX) Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Janux Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from 2022 to 2024.
  • Janux Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending March 31, 2024 was $3.72M, a 2.99% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $3.72M +$108K +2.99% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $3.61M +$106K +3.02% Dec 31, 2023 10-K 2024-03-08
Q3 2023 $3.61M +$106K +3.02% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.61M +$106K +3.02% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.61M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.51M Dec 31, 2022 10-K 2023-03-10
Q3 2022 $3.51M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.51M Jun 30, 2022 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.